Dow Inc.
DOW
$37.32
-3.06%
Dow Inc. is a diversified global chemicals producer, operating in the Basic Materials sector with a focus on industrial chemicals. The company is a leading producer of key materials like polyethylene, ethylene oxide, and silicone rubber, serving a wide range of consumer and industrial end markets. The current investor narrative is dominated by a volatile mix of significant geopolitical supply chain shocks and a subsequent de-escalation, as recent news highlights the severe impact of Middle East tensions on its Q1 results, followed by a market rally on eased fears, positioning Dow as a barometer for global industrial health and commodity price sensitivity.…
DOW
Dow Inc.
$37.32
Related headlines
Investment Opinion: Should I buy DOW Today?
Rating: Hold. The core thesis is that DOW is a deeply cyclical stock in the midst of a powerful technical rally that has largely priced in a near-perfect fundamental recovery, leaving asymmetric risk to the downside if execution falters.
Supporting this Hold rating are several conflicting data points. On the positive side, the stock trades at a historically low PS ratio of 0.42, has seen bullish analyst upgrades, and offers a 3.5% dividend yield. However, these are counterbalanced by severe fundamental distress: a -9.1% YoY revenue decline, a -6.56% net margin, negative free cash flow, and a forward P/E of 19.5x that requires flawless earnings delivery. The implied upside is contingent on hitting the analyst EPS target of $2.27, which is far from certain given the Q4 loss of -$2.15 per share.
The two biggest risks that could invalidate a Hold thesis are 1) a further deterioration in free cash flow forcing a dividend cut, and 2) a Q2 2026 earnings miss that shatters the recovery narrative. This Hold would upgrade to a Buy if the forward P/E compresses below 15x while the earnings trajectory remains intact, or if quarterly free cash flow turns positive. It would downgrade to a Sell if revenue decline accelerates beyond -10% YoY or if gross margins fail to recover above 10%. Currently, the stock appears fairly valued to slightly overvalued relative to its immediate fundamentals, but undervalued on a long-term cyclical trough basis.
Sign up to view all
DOW 12-Month Price Forecast
DOW presents a high-conviction chart but low-conviction fundamentals. The technical breakout is compelling and suggests the market is forward-looking, betting heavily on a cyclical rebound. However, the magnitude of the recent profitability collapse and cash burn cannot be ignored. The neutral stance reflects this dichotomy: the risk/reward is balanced at current levels. The stance would upgrade to bullish on confirmation of positive quarterly free cash flow and sequential revenue growth. It would turn bearish if the stock breaks below key technical support at $35.60 (the April low) on high volume, signaling the failure of the recovery trade.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Dow Inc.'s 12-month outlook, with a consensus price target around $48.52 and implied upside of +30.0% versus the current price.
Average Target
$48.52
10 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
10
covering this stock
Price Range
$30 - $49
Analyst target range
Analyst coverage for Dow is active, with 10 firms providing estimates. The consensus sentiment appears cautiously optimistic, leaning bullish, as evidenced by recent institutional rating actions including upgrades from Citigroup (to Buy) and RBC Capital (to Outperform) in March 2026. The average target price is not explicitly provided in the data, but analyst estimates focus on an average EPS of $2.27 and revenue of $45.94 billion for the forward period, implying expectations for a significant earnings rebound from current levels. The target range for estimated EPS is from a low of $2.08 to a high of $2.49, indicating a relatively tight spread of about 19%, which suggests moderate consensus on the earnings recovery trajectory. The high target likely assumes a successful execution of cost-saving initiatives, a full normalization of supply chains, and a robust rebound in chemical demand and pricing. The low target likely factors in the risk of prolonged margin pressure, competitive challenges, or a slower-than-expected economic recovery impacting volumes. The recent flurry of rating actions in March signals high analyst engagement with the evolving story, with the overall direction of revisions being positive.
Bulls vs Bears: DOW Investment Factors
The investment debate for DOW is a classic battle between a powerful technical recovery and deeply troubled fundamentals. The bull case, currently supported by stronger evidence from the price action and analyst sentiment, hinges on a swift cyclical and geopolitical normalization that restores profitability. The bear case is grounded in the severe and quantifiable deterioration of margins, cash flow, and revenue. The single most important tension is the timing and magnitude of the earnings recovery. If DOW can deliver on the analyst consensus of $2.27 EPS, the stock is undervalued. If the operational challenges persist longer than a quarter or two, the current premium forward multiple will compress, and the negative cash flow could threaten the dividend, validating the bear thesis.
Bullish
- Powerful Technical Uptrend: The stock has surged 68.93% over the past six months and 31.97% over the past year, breaking out from its 52-week low of $20.40. This momentum, coupled with a beta of 0.495, suggests a strong, low-volatility recovery driven by easing geopolitical fears and a cyclical rebound narrative.
- Analyst Upgrades & Earnings Recovery: Recent upgrades from Citigroup and RBC Capital to Buy/Outperform signal bullish sentiment. Analysts forecast a sharp EPS recovery to an average of $2.27, implying a forward P/E of 19.5x, which prices in a significant profit rebound from the current net loss of -$1.54 billion.
- Attractive Valuation on Sales Basis: Trading at a trailing Price-to-Sales ratio of 0.42 and an EV/Sales of 1.17, DOW is near the bottom of its historical valuation range (as high as 4.01 in Q1 2021). This deep-value multiple suggests most pessimism is priced in, offering a margin of safety if fundamentals stabilize.
- Geopolitical Risk Premium Easing: Recent news confirms the Strait of Hormuz has reopened, removing a major supply chain shock that severely impacted Q1 results. This de-escalation is a direct catalyst for margin recovery, as input cost pressures and logistical bottlenecks are expected to normalize.
Bearish
- Severe Profitability Deterioration: Q4 2025 results show a catastrophic net loss of -$1.54 billion and a gross margin of only 5.79%, down from 6.91% in Q3. The trailing EPS is -$0.16 with a net margin of -6.56%, indicating the company is deeply unprofitable with severe margin compression.
- Negative Free Cash Flow & ROE: Trailing twelve-month free cash flow is deeply negative at -$2.61 billion, and ROE is -16.39%. This indicates the company is burning cash and destroying shareholder value, raising concerns about its ability to fund the dividend and operations without external financing.
- Revenue Contraction & Cyclical Pressure: Q4 revenue of $9.46 billion represents a -9.1% year-over-year decline, continuing a sequential downtrend from $10.43 billion in Q1 2025. This highlights DOW's acute sensitivity to cyclical downturns and commodity price swings, challenging near-term growth.
- Forward P/E Premium to Market: The forward P/E of 19.5x is above the market average, implying the market expects a swift and robust earnings recovery. This premium valuation leaves little room for error; any delay in the profit rebound could trigger significant multiple compression.
DOW Technical Analysis
The stock is in a powerful, sustained uptrend, evidenced by a 1-year price change of +31.97% and a 6-month surge of +68.93%. As of the latest close at $40.29, the price is trading near the top of its 52-week range, approximately 94% of the way from its low of $20.40 to its high of $42.74, indicating strong momentum but also proximity to a major technical resistance level. Recent momentum shows a slight deceleration from the longer-term trend, with a 1-month price change of -0.98%, which contrasts sharply with the robust 3-month gain of +46.24%; this divergence suggests a period of consolidation or profit-taking after the explosive rally earlier in the year, potentially setting the stage for the next directional move. Key technical support is anchored at the 52-week low of $20.40, while immediate resistance sits at the 52-week high of $42.74. A decisive breakout above $42.74 would signal a continuation of the bull trend, whereas a failure and reversal could see a test of lower support levels. The stock's beta of 0.495 indicates it has been significantly less volatile than the broader market (SPY) over the measured period, which, combined with a 1-month relative strength of -10.96, suggests it has recently underperformed the market rally, possibly due to its specific fundamental headwinds. The price action shows the stock experienced a dramatic rally from late February through March, peaking near $42 in late March, followed by a volatile consolidation phase between approximately $35.60 and $41.87. The high-volume spike on March 12th to $37.58 likely coincided with major news flow, and the subsequent range-bound trading indicates a battle between bulls capitalizing on the broader 'peace trade' and bears concerned with the company's specific fundamental challenges, such as the reported Q1 revenue miss and widening loss.
Beta
0.45
0.45x market volatility
Max Drawdown
-40.8%
Largest decline past year
52-Week Range
$20-$43
Price range past year
Annual Return
+31.2%
Cumulative gain past year
| Period | DOW Return | S&P 500 |
|---|---|---|
| 1m | -9.9% | +11.0% |
| 3m | +17.4% | +5.9% |
| 6m | +67.4% | +9.0% |
| 1y | +31.2% | +30.4% |
| ytd | +53.8% | +7.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
DOW Fundamental Analysis
Dow's revenue trajectory is under significant pressure, with the most recent quarterly revenue of $9.46 billion representing a -9.1% year-over-year decline. The multi-quarter trend shows a consistent sequential deterioration from $10.43 billion in Q1 2025, indicating the cyclical and geopolitical headwinds are having a material impact. Segment data reveals Packaging & Specialty Plastics as the largest contributor at $4.74 billion in the latest period, but without percentage growth data, the overall picture is one of top-line contraction which challenges the near-term growth thesis. Profitability has deteriorated sharply, with the company reporting a net loss of -$1.54 billion and a gross margin of only 5.79% for Q4 2025. This compares unfavorably to a net income of $62 million and a 6.91% gross margin in the prior quarter (Q3 2025), highlighting severe margin compression and volatility. The company is currently unprofitable on a trailing basis, with an EPS of -$0.16 and a net margin of -6.56%, though a forward PE of 19.47 suggests the market anticipates a return to profitability, which is contingent on easing input cost pressures and supply chain normalization. The balance sheet shows moderate leverage with a debt-to-equity ratio of 1.22, and reasonable liquidity with a current ratio of 1.97. However, cash flow generation is a critical concern, with trailing twelve-month free cash flow deeply negative at -$2.61 billion and an operating cash flow of $1.03 billion for the latest quarter. The negative FCF and an ROE of -16.39% indicate the company is not currently generating sufficient internal cash to fund operations and its dividend comfortably, increasing its reliance on external financing or asset sales during this downturn.
Quarterly Revenue
$9.5B
2025-12
Revenue YoY Growth
-0.09%
YoY Comparison
Gross Margin
+0.05%
Latest Quarter
Free Cash Flow
$-2.6B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is DOW Overvalued?
Given the negative trailing net income, the primary valuation metric selected is the Price-to-Sales (PS) ratio. Dow trades at a trailing PS ratio of 0.42 and an EV/Sales of 1.17. The forward PE ratio of 19.47x is also cited, as it reflects market expectations for a return to profitability, with the wide gap between the negative trailing PE and positive forward PE underscoring the anticipated earnings recovery priced into the stock. Compared to industry averages, Dow's valuation presents a mixed picture. Its PS ratio of 0.42 is difficult to contextualize without a specific sector average, but its forward PE of 19.47x is above the market average, suggesting the market is assigning a premium for its cyclical recovery potential and market-leading position. This premium must be justified by a swift rebound in profitability and volume growth as geopolitical tensions ease, otherwise the stock appears fully valued or expensive relative to its current depressed earnings power. Historically, the current PS ratio of 0.42 is near the bottom of its own historical range observed in the provided data, which has seen PS ratios as high as 4.01 in Q1 2021. This suggests the stock is being valued at a point reflecting significant fundamental distress and pessimistic expectations. Trading near historical valuation lows can indicate a deep value opportunity if the company's fundamentals are poised for a cyclical recovery, but it also carries the risk of value trap if the operational challenges persist longer than anticipated.
PE
-6.3x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -133x~66x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
27.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are acute. DOW is currently burning cash, with TTM free cash flow at -$2.61 billion and a deeply negative ROE of -16.39%. This cash burn, combined with a debt-to-equity ratio of 1.22, increases reliance on external financing. Profitability has collapsed, with Q4 gross margins at 5.79% and a net loss of -$1.54 billion, indicating severe vulnerability to input cost inflation and weak pricing power. Revenue is also contracting sequentially, down -9.1% YoY, showing dependence on a cyclical rebound that may be delayed.
Market & Competitive Risks center on valuation and macro sensitivity. The stock trades at a forward P/E of 19.5x, a premium that demands a flawless earnings recovery. Failure to meet the $2.27 EPS consensus could trigger rapid multiple compression. As a global chemicals producer, DOW is a barometer for industrial health and remains highly sensitive to commodity prices, as evidenced by the recent 14% crude oil crash on geopolitical de-escalation news. Its low beta of 0.495 is deceptive; it reflects past stability but does not immunize it from sector-specific downturns or a slower-than-expected global economic recovery impacting chemical demand.
Worst-Case Scenario involves a prolonged industrial recession coupled with sustained margin pressure. In this adverse case, the anticipated 2026 earnings rebound fails to materialize, free cash flow remains negative, and the company is forced to cut its prized dividend. This could trigger a re-rating to distressed valuation levels. A realistic downside could see the stock retesting its 52-week low of $20.40, representing a potential loss of approximately -49% from the current price of $40.29. The historical max drawdown of -41.4% provides a benchmark for the volatility inherent in this cyclical name.
FAQ
The key risks are, in order of severity: 1) Financial Risk: The company is burning cash, with TTM FCF at -$2.61 billion, calling into question its ability to maintain the dividend without borrowing. 2) Profitability Risk: Gross margins collapsed to 5.79% in Q4, and the net margin is -6.56%, indicating severe operational distress. 3) Cyclical/Macro Risk: Revenue is declining YoY (-9.1%), and the business is highly sensitive to global industrial demand and commodity price swings. 4) Valuation Risk: The forward P/E of 19.5x leaves the stock vulnerable to multiple compression if the earnings rebound is delayed or weaker than expected.
The 12-month forecast is bifurcated, with a 50% probability base case target range of $40-$47, aligning with analyst expectations for a gradual earnings recovery. The bullish case (30% probability) targets $48-$55, requiring a swift V-shaped rebound in margins and demand. The bearish case (20% probability) warns of a drop to $20-$30 if the recovery stalls and cash burn continues. The most likely scenario is the base case, where DOW meets the consensus EPS of $2.27 but the stock struggles to make new highs due to lingering cyclical concerns, resulting in range-bound trading.
DOW's valuation presents a paradox. On a sales basis, it appears deeply undervalued, trading at a trailing PS ratio of 0.42, near the bottom of its historical range. On an earnings basis, it appears fully valued or slightly overvalued, with a forward P/E of 19.5x that demands a flawless profit recovery from current losses. Compared to the market, the forward P/E is at a premium. The valuation implies the market is paying a fair price for a company it expects to return to significant profitability, leaving little margin for error. It is undervalued as a cyclical asset but overvalued as a current going concern.
DOW is a speculative buy for investors with a high risk tolerance and a belief in a near-term industrial cycle rebound. The stock offers a compelling 3.5% dividend yield and trades at a historically low Price-to-Sales ratio of 0.42. However, it carries significant risk, as the company is currently unprofitable with negative free cash flow. The average analyst EPS target of $2.27 implies substantial upside if achieved, but failure could lead to a -49% drawdown to the 52-week low. It is a good buy only for those who can stomach volatility and are confident in a 2026 earnings recovery.
DOW is primarily suitable for a medium-to-long-term investment horizon of 2-3 years to fully capture a potential cyclical upswing. Its low beta of 0.495 and high dividend yield provide some stability for long-term holders. However, its current fundamental volatility and dependence on an earnings recovery make it a poor candidate for short-term trading, as news flow can cause sharp swings (e.g., the recent 14% oil price crash). Investors should be prepared to hold through potential quarterly earnings volatility. A minimum holding period of 12-18 months is suggested to assess whether the operational turnaround is materializing.